If your email program has trouble displaying this email, view as a webpage.

Update: SARS-CoV-2 Viral Mutations Impact on COVID-19 Tests

Today, the U.S. Food and Drug Administration (FDA) updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to include information about genotyping tests authorized for the identification and differentiation of specific SARS-CoV-2 mutations, lineages, or variants.

Questions?

If you have questions about this update, email COVID19DX@fda.hhs.gov